CD274 and neoplasm: Secondly, exosomal PD-L1 is bound to anti-PD-L1 antibody and mediates resistance to anti-PD-1/PD-L1 immune checkpoint therapy and blocks the activation of T cells, thereby promoting tumor growth [29,38,88].